Posted inComunicati
Zemcelpro® (dorocubicel) Positive Results in High- and Very High-Risk Blood Cancers to be Reported at the EBMT 2026 Annual Meeting
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE MONTREAL, March 10, 2026 /PRNewswire/ -- ExCellThera Inc. (ExCellThera), a…









